Publications by authors named "Tomas Lyons"

Claim this Profile
E
Effects of transcutaneous electrical nerve stimulation for the treatment of pain and respiratory function following mastopexy with augmentation: study protocol for a randomized controlled trial.
Esteban Fortuny Pacheco, Tomas Valverde Lyons, Richard Eloin Liebano

Trials· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.
Diana G Wang, Dulce M Barrios, Victoria S Blinder, Jacqueline F Bromberg, Pamela R Drullinsky, Tomas Lyons

Breast Cancer Res Treat· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapies for Triple-Negative Breast Cancer.
Tomas G Lyons

Curr Treat Options Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Novel Therapeutics in Triple-Negative Breast Cancer.
Tomas G Lyons, Tiffany A Traina

Adv Exp Med Biol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resurrection of PARP Inhibitors in Breast Cancer.
Tomas G Lyons, Mark E Robson

J Natl Compr Canc Netw· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Inhibitors in the Treatment of Breast Cancer.
Tomas G Lyons, Maura N Dickler, Elizabeth E Comen

Curr Oncol Rep· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods.
Odharnaith O'Brien, Tomas Lyons, Sandra Murphy, Linda Feeley, Derek Power

J Clin Pathol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic therapy for esophagogastric cancer: targeted therapies.
Tomas G Lyons, Geoffrey Y Ku

Chin Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic therapy for esophagogastric cancer: immune checkpoint inhibition.
Tomas G Lyons, Geoffrey Y Ku

Chin Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.
Grainne M O'Kane, Tomas G Lyons, Gabrielle C Colleran, Marzuki Wan Ahmad, Scheryll Alken

Oncol Res Treat· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How can clinical research help our understanding of trastuzumab-related cardiotoxicity?
Tomás G Lyons, Patrick G Morris

EBioMedicine· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of vismodegib : a new therapeutic agent in the treatment of basal cell carcinoma.
Tomas G Lyons, Grainne M O'Kane, Catherine M Kelly

Expert Opin Drug Saf· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis